Accord Healthcare Ltd
Overview
Accord Healthcare Ltd is a subsidiary of Intas Pharmaceuticals, operating in the pharmaceutical industry. It focuses on developing and marketing affordable generic medications across various therapeutic areas.
Core services & business areas
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Accord Healthcare Ltd is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Accord Healthcare Ltd holds 0 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- DOCETAXEL TRIHYDRATE APIInactive2008-10-23
- ANHYDROUS DOCETAXELInactive2007-06-11
- PACLITAXEL APIInactive2004-09-02
FDA compliance signals
50 FDA enforcement records linked to this company.
- recall — Class II2026-07-08
Subpotent Drug
- recall — Class II2025-10-15
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
- recall — Class II2025-07-23
Subpotent Drug: Assay below the approved specification
- recall — Class II2025-07-23
Subpotent Drug: Assay below the approved specification
- recall — Class II2025-07-23
Subpotent Drug: Assay below the approved specification
- recall — Class II2025-07-23
Subpotent Drug: Assay below the approved specification
- recall — Class II2025-07-23
Subpotent Drug: Assay below the approved specification
- recall — Class II2025-07-23
Subpotent Drug: Assay below the approved specification
- recall — Class II2025-07-23
Subpotent Drug: Assay below the approved specification
- recall — Class II2025-05-07
Subpotent
- recall — Class II2025-05-07
Subpotent
- recall — Class II2025-05-07
Subpotent
- recall — Class II2025-05-07
Subpotent
- recall — Class II2024-12-11
Subpotent drug
- recall — Class II2024-11-06
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Is this Accord Healthcare Ltd? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.